
Chicago-based accelerator for technology companies serving the real estate industry

Transatlantic biotechnology venture firm building life sciences companies that turn science into new medicines

SR One is a biotechnology venture capital firm that works with founders and entrepreneurs to turn research into medicines. It has been creating companies since 1985.
The firm targets gaps in treatment options across oncology, immunology and rare diseases. It works with founders whose science addresses unmet clinical need.
Profile written by TrustList from the business's own published information, Oct 2026.
As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.
No questions yet. Be the first to ask about SR One.
Similar listings buyers compare against this one.

Chicago-based accelerator for technology companies serving the real estate industry

Desktop office software with a word processor, spreadsheet, presentations and PDF tools for individuals

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Semiconductor and sensing company selling components and design tools to engineers in industrial, automotive and healthcare markets

Global startup accelerator and early-stage investor running city and sector programmes for founders

Venture arm of a crypto exchange investing in early-stage web3 and blockchain startups
Everything here links back to the same verified catalogue. Pick your next stop.